Emisphere Technologies
Drug Delivery Development for Advanced Oral Formulations
German pharmaceutical research company Evotec has acquired US-based drug discovery and development company Aptuit for $300m.
German pharmaceutical research company Evotec has acquired US-based drug discovery and development company Aptuit for $300m.
The acquisition will support Evotec’s long-term strategy to become a leader in drug discovery and development.
Biological products provider BioreclamationIVT has acquired biopharmaceutical company Asterand Bioscience.
The acquisition will enable BioreclamationIVT to expand its disease-state biospecimen capabilities.
Both companies involved in the acquisition are based in the US.
Drug Delivery Development for Advanced Oral Formulations
Nanofibre and Nanoparticle Production Systems
SaaS Platform Decentralizing Clinical Research at Scale